6th Jul 2005 12:23
GlaxoSmithKline PLC06 July 2005 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. The Administrators of the GlaxoSmithKline US Retirement Savings Plan ("thePlan") notified GlaxoSmithKline plc on 5 July 2005, that as a result of amovement in the fund on 1 July 2005, the number of Ordinary Share ADRs held bythe fund had changed from 18,298,991 to 18,354,038 at an average price of$48.51. The Plan is a discretionary fund of which all employees or former employees ofGlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Two of theCompany's directors, Dr J P Garnier and Dr T Yamada are therefore potentiallyinterested in the shares held in the fund from time to time in the same way asother employees or former employees of GlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M Bicknell Company Secretary 6 July 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline